Logo
TechDefused
Gilead

Gilead pays $7.8bn to take full control of a CAR T therapy that could win FDA approval by year-end

Feb 23, 2026
IanLyall@RTBb5 profile imagefeatured creator badge
Ian Lyall
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy